123 related articles for article (PubMed ID: 35179092)
1. Oncologic impact of concomitant prostate cancer characteristics at the time of radical cystoprostatectomy for bladder cancer: a population-based analysis.
Kachanov M; Vetterlein MW; Soave A; Karakiewicz PI; Liakos N; Jankowski T; Pose RM; Mandrek M; Fisch M; Witt JH; Graefen M; Leyh-Bannurah SR
Aging Male; 2022 Dec; 25(1):54-61. PubMed ID: 35179092
[TBL] [Abstract][Full Text] [Related]
2. Concomitant Gleason Score ≥ 7 prostate cancer is an independent prognosticator for poor survival in nonmetastatic bladder cancer patients undergoing radical cystoprostatectomy.
Thomas C; Giesswein A; Hainz M; Stein R; Rubenwolf P; Roos FC; Neisius A; Nestler S; Hampel C; Jäger W; Wiesner C; Thüroff JW
Int Urol Nephrol; 2015 Nov; 47(11):1789-96. PubMed ID: 26377495
[TBL] [Abstract][Full Text] [Related]
3. Impact of Prostate Involvement on Outcomes in Patients Treated with Radical Cystoprostatectomy for Bladder Cancer.
Moschini M; Shariat SF; Freschi M; Soria F; Abufaraj M; Gandaglia G; Dell'Oglio P; Mattei A; Damiano R; Salonia A; Montorsi F; Briganti A; Gallina A; Colombo R
Urol Int; 2017; 98(3):290-297. PubMed ID: 28142141
[TBL] [Abstract][Full Text] [Related]
4. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
[TBL] [Abstract][Full Text] [Related]
5. Incidental prostate cancer in patients with muscle-invasive bladder cancer who underwent radical cystoprostatectomy.
Tanaka T; Koie T; Ohyama C; Hashimoto Y; Imai A; Tobisawa Y; Hatakeyama S; Yamamoto H; Yoneyama T; Horiguchi H; Kodama H; Yoneyama T
Jpn J Clin Oncol; 2017 Nov; 47(11):1078-1082. PubMed ID: 28973396
[TBL] [Abstract][Full Text] [Related]
6. Very long-term survival patterns of young patients treated with radical prostatectomy for high-risk prostate cancer.
Dell'Oglio P; Karnes RJ; Joniau S; Spahn M; Gontero P; Tosco L; Fossati N; Kneitz B; Chlosta P; Graefen M; Marchioro G; Bianchi M; Sanchez-Salas R; Karakiewicz PI; Poppel HV; Montorsi F; Briganti A;
Urol Oncol; 2016 May; 34(5):234.e13-9. PubMed ID: 26706120
[TBL] [Abstract][Full Text] [Related]
7. Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis.
Abdollah F; Sun M; Jeldres C; Schmitges J; Thuret R; Djahangirian O; Tian Z; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
BJU Int; 2012 Feb; 109(4):564-9. PubMed ID: 21810161
[TBL] [Abstract][Full Text] [Related]
8. Assessment of 5-year overall survival in bladder cancer patients with incidental prostate cancer identified at radical cystoprostatectomy.
Wu S; Lin SX; Lu M; Subtelny AO; Wang Z; Dahl DM; Olumi AF; Wu CL
Int Urol Nephrol; 2019 Sep; 51(9):1527-1535. PubMed ID: 31183659
[TBL] [Abstract][Full Text] [Related]
9. Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy.
Pettus JA; Al-Ahmadie H; Barocas DA; Koppie TM; Herr H; Donat SM; Dalbagni G; Reuter VE; Olgac S; Bochner BH
Eur Urol; 2008 Feb; 53(2):370-5. PubMed ID: 17689003
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and clonality of synchronous primary carcinomas in the bladder and prostate.
Jing Y; Zhang R; Ma P; Cai MC; Zhuang G; Chen H
J Pathol; 2018 Jan; 244(1):5-10. PubMed ID: 29023722
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic characteristics and outcomes of prostate cancer incidentally discovered at the time of radical cystoprostatectomy: a population-based cohort study.
Wu K; Liu X; Tang Y; Wang X; Li X
Int J Surg; 2024 Mar; ():. PubMed ID: 38537072
[TBL] [Abstract][Full Text] [Related]
12. Concomitant carcinoma in situ may not be a prognostic factor for patients with bladder cancer following radical cystectomy: a PRISMA-compliant systematic review and meta-analysis.
Zhang L; Wu B; Zha Z; Zhao H; Yuan J; Jiang Y
World J Urol; 2020 Jan; 38(1):129-142. PubMed ID: 30919100
[TBL] [Abstract][Full Text] [Related]
13. Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis.
Briganti A; Spahn M; Joniau S; Gontero P; Bianchi M; Kneitz B; Chun FK; Sun M; Graefen M; Abdollah F; Marchioro G; Frohenberg D; Giona S; Frea B; Karakiewicz PI; Montorsi F; Van Poppel H; Jeffrey Karnes R;
Eur Urol; 2013 Apr; 63(4):693-701. PubMed ID: 22959192
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer incidentally discovered at the time of radical cystoprostatectomy does not decrease overall survival: Results from a large Chinese medical center.
Tang S; Hao H; Fang D; Zheng W; Ge P; Su X; He Q; Yang X; Shen Q; Li X; Yu W; Lin J; Zhou L
Int Braz J Urol; 2018; 44(2):258-266. PubMed ID: 29219277
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Features and Prognostic Value of Incidental Prostatic Adenocarcinoma in Radical Cystoprostatectomy Specimens: A Systematic Review and Meta-Analysis of 13,140 Patients.
Fahmy O; Khairul-Asri MG; Schubert T; Renninger M; Stenzl A; Gakis G
J Urol; 2017 Feb; 197(2):385-390. PubMed ID: 27569436
[TBL] [Abstract][Full Text] [Related]
16. Predicting prostate cancer-specific outcome after radical prostatectomy among men with very high-risk cT3b/4 PCa: a multi-institutional outcome study of 266 patients.
Moltzahn F; Karnes J; Gontero P; Kneitz B; Tombal B; Bader P; Briganti A; Montorsi F; Van Poppel H; Joniau S; Spahn M
Prostate Cancer Prostatic Dis; 2015 Mar; 18(1):31-7. PubMed ID: 25535100
[TBL] [Abstract][Full Text] [Related]
17. Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer.
Guo X; Liu M; Hou H; Liu S; Zhang X; Zhang Y; Wu P; Pang C; Wang J
Int J Clin Oncol; 2019 Aug; 24(8):957-965. PubMed ID: 30903422
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics of incidental prostate cancer discovered from radical cystoprostatectomy specimen: a multicenter French study.
Pignot G; Salomon L; Neuzillet Y; Masson-Lecomte A; Lebacle C; Patard JJ; Lunardi P; Rischmann P; Pasticier G; Bernhard JC; Cohen J; Timsit MO; Verkarre V; Peyronnet B; Verhoest G; Le Goux C; Zerbib M; Brecheteau F; Bigot P; Larre S; Murez T; Thuret R; Lacarriere E; Champy C; Roupret M; Comperat E; Berger J; Descazeaud A; Toledano H; Bastide C; Lavilledieu S; Avances C; Delage F; Valeri A; Molimard B; Houlgatte A; Gres P; Donnaint A; Kleinclauss F; Legal S; Doerfler A; Koutlidis N; Cormier L; Hetet JF; Colls P; Arvin-Berod A; Rambeaud JJ; Quintens H; Soulie M; Pfister C;
Ann Surg Oncol; 2014 Feb; 21(2):684-90. PubMed ID: 24170436
[TBL] [Abstract][Full Text] [Related]
19. Radical cystectomy in bladder cancer patients previously treated for prostate cancer: Insights from a large European multicentric series.
Tappero S; Chierigo F; Parodi S; Bandini M; Moschini M; Cucchiara V; Chessa F; Di Maida F; Mari A; Manfredi M; Mantica G; Cerruto MA; Fiori C; Schiavina R; Briganti A; Suardi N; Brunocilla E; Antonelli A; Porpiglia F; Minervini A; Montorsi F; Terrone C
Surg Oncol; 2023 Oct; 50():101973. PubMed ID: 37454433
[TBL] [Abstract][Full Text] [Related]
20. Radical Cystectomy in Pathological T4a and T4b Bladder Cancer Patients: Is There Any Space for Sub Stratification?
Moschini M; Zamboni S; Mattei A; Baumeister P; Di Bona C; Cornelius J; Shariat SF; Freschi M; Zaffuto E; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A;
Urol Int; 2019; 102(3):269-276. PubMed ID: 30695782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
